DefiniGEN will be attending World Organoid and Organ on a Chip 2025 conference hosted in Cambridge, ...
DefiniGEN is excited to announce our participation in the upcoming ELRIG German Forum: Target Innova...
Our CBO,Heidi Kingdon Jonesand Director of Business Development, NA,French Lewis, IIIwill be in atte...
We’re excited to share that DefiniGEN will be at the Society of Toxicology (SOT) Annual Meeting, pre...
We’re proud to share that our Head of R&D,Nikolaos Nikolaouhas been selected to give an oral pre...
We are proud to announce that our CEO,Chris Kirton, PhD, will be speaking at the upcomingNational Ce...
Join us at this one-day ELRIG forum to reflect on the challenges and opportunities of integrating th...
We will be presenting our poster titled: Development of an iPSC-derived hepatocyte and hepatic stell...
The Milner Therapeutics Symposium takes place annually in Cambridge, UK, hosting ~500 delegates in p...
Our head of R&D, Nikolaos Nikolaou, DPhil and our Marketing Manager, Haris Choudhery, PhD, will ...